Global CellCulture Media for Vaccine Market, by Media Type (Bovine Derived, PorcineDerived, and Animal Free/Serum Free Cell Culture), by Application (HumanVaccine and Animal Vaccine), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 1,235.5million in 2017 and is projected to exhibit a CAGR of 7.7% over the forecast period(2018 – 2026).
Key players in the market arefocused on research and development in order to develop novel research gradeproducts to cater the need of researchers. For instance, in November 2017,Proliant Biologicals launched New Zealand manufactured Reagent Grade (FattyAcid-Free) BSA. The product is derived from New Zealand-origin healthy animals.Moreover, increasing number of government initiatives to prevent certaindiseases and epidemic caused due to vaccine-preventable diseases is expected toboost the market growth. Furthermore, increasing number of countries areconducting national immunization programs to provide vaccination and promoteawareness regarding advantages of vaccination to fight fatal diseases withnatural immunity among adults as well as children. For instance, in 2015, theCenters for Disease Control and Prevention (CDC), the Food and DrugAdministration (FDA), and the National Institutes of Health (NIH) partneredwith the U.S. Department of Health and Human Services Biomedical AdvancedResearch and Development Authority (BARDA) to support the advanced developmentof new and better influenza vaccines as a part of inter-agency governmenteffort in the U.S.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2608
Browse 33 Market Data Tables and27 Figures spread through 197 Pages and in-depth TOC on ‘Cell Culture Media forVaccine Market’- Global Forecast to 2026, by Media Type (Bovine Derived,Porcine Derived, and Animal Free/Serum Free Cell Culture), by Application(Human Vaccine and Animal Vaccine), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa)
Key players in the market arefocused on adopting strategies such as mergers and acquisitions to enhancetheir product portfolio. For instance, In November 2015, Merck KGaA, which is aparent company of Merck Millipore, acquired the U.S.-based life sciencecompany, Sigma-Aldrich Corporation, at US$ 17 Bn through its U.S. subsidiaryEMD Millipore. A combined entity known as MilliporeSigma was formed in the U.S.market and this acquisition made Merck Millipore one of the top three playersin the global life science market.
Key Takeaways of the Global CellCulture Media for Vaccine Market:
The global cell culture media forvaccine market is expected to exhibit a CAGR of 7.7 % over the forecast period,owing to increasing prevalence of infectious diseases, increasing number ofgovernment initiatives, and increasing availability of innovative bovine bloodplasma derivatives. For instance, in August 2017, Animal Free Research UK andthe 3Rs-Centre Utrecht Life Sciences launched the Fetal Calf Serum (FCS)-free database.The database enables researchers to identify serum-free media for specific celltypes, thereby contributing to the adoption of animal free media for research.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/cell-culture-media-for-vaccine-market-2608
Among application type, humanvaccine segment is estimated to hold a dominant position in the cell culturemedia for vaccine market in 2018, owing to higher usage of bovine derived serumproducts in biotechnology research, vaccine production, cloning, and in vitrofertilization
Among media type, bovine derivedis estimated to hold a dominant position in the cell culture media for vaccinemarket in 2018, as manufacturing of viral vaccines require fetal bovine serumor other sera as a source of nutrition or growth media for the virus growth
Key players operating in theglobal cell culture media for vaccine market include, HiMedia Laboratories,Thermo Fisher Scientific Inc., Merck KGaA, General Electric Company, SartoriusAG, Proliant, Inc., Bovogen Biologicals Pty. Ltd., Rocky Mountain Biologicals,Valley Biomedical, Moregate BioTech, Atlanta Biologicals, Creative-Biolabs,Life Technologies (India) Pvt Ltd., Axil Scientific Pte Ltd., IndianImmunologicals Limited, Serum Institute of India Pvt. Ltd., Sisco ResearchLaboratories Pvt. Ltd., and Valneva SE
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2608
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
